242 related articles for article (PubMed ID: 14551214)
1. Remodeling of cardiolipin by phospholipid transacylation.
Xu Y; Kelley RI; Blanck TJ; Schlame M
J Biol Chem; 2003 Dec; 278(51):51380-5. PubMed ID: 14551214
[TBL] [Abstract][Full Text] [Related]
2. Mechanism for Remodeling of the Acyl Chain Composition of Cardiolipin Catalyzed by Saccharomyces cerevisiae Tafazzin.
Abe M; Hasegawa Y; Oku M; Sawada Y; Tanaka E; Sakai Y; Miyoshi H
J Biol Chem; 2016 Jul; 291(30):15491-502. PubMed ID: 27268057
[TBL] [Abstract][Full Text] [Related]
3. Lysocardiolipin formation and reacylation in isolated rat liver mitochondria.
Schlame M; Rüstow B
Biochem J; 1990 Dec; 272(3):589-95. PubMed ID: 2268287
[TBL] [Abstract][Full Text] [Related]
4. Formation of molecular species of mitochondrial cardiolipin. 1. A novel transacylation mechanism to shuttle fatty acids between sn-1 and sn-2 positions of multiple phospholipid species.
Malhotra A; Xu Y; Ren M; Schlame M
Biochim Biophys Acta; 2009 Apr; 1791(4):314-20. PubMed ID: 19416660
[TBL] [Abstract][Full Text] [Related]
5. The Basis for Acyl Specificity in the Tafazzin Reaction.
Schlame M; Xu Y; Ren M
J Biol Chem; 2017 Mar; 292(13):5499-5506. PubMed ID: 28202545
[TBL] [Abstract][Full Text] [Related]
6. Expression of human monolysocardiolipin acyltransferase-1 improves mitochondrial function in Barth syndrome lymphoblasts.
Mejia EM; Zegallai H; Bouchard ED; Banerji V; Ravandi A; Hatch GM
J Biol Chem; 2018 May; 293(20):7564-7577. PubMed ID: 29563154
[TBL] [Abstract][Full Text] [Related]
7. Human trifunctional protein alpha links cardiolipin remodeling to beta-oxidation.
Taylor WA; Mejia EM; Mitchell RW; Choy PC; Sparagna GC; Hatch GM
PLoS One; 2012; 7(11):e48628. PubMed ID: 23152787
[TBL] [Abstract][Full Text] [Related]
8. Role of Acyl Chain Composition of Phosphatidylcholine in Tafazzin-Mediated Remodeling of Cardiolipin in Liposomes.
Abe M; Sawada Y; Uno S; Chigasaki S; Oku M; Sakai Y; Miyoshi H
Biochemistry; 2017 Nov; 56(47):6268-6280. PubMed ID: 29091407
[TBL] [Abstract][Full Text] [Related]
9. Acylation of monolysocardiolipin in rat heart.
Ma BJ; Taylor WA; Dolinsky VW; Hatch GM
J Lipid Res; 1999 Oct; 40(10):1837-45. PubMed ID: 10508203
[TBL] [Abstract][Full Text] [Related]
10. The enzymatic function of tafazzin.
Xu Y; Malhotra A; Ren M; Schlame M
J Biol Chem; 2006 Dec; 281(51):39217-24. PubMed ID: 17082194
[TBL] [Abstract][Full Text] [Related]
11. Identification of the human mitochondrial linoleoyl-coenzyme A monolysocardiolipin acyltransferase (MLCL AT-1).
Taylor WA; Hatch GM
J Biol Chem; 2009 Oct; 284(44):30360-71. PubMed ID: 19737925
[TBL] [Abstract][Full Text] [Related]
12. Selective acyl transfer in the reacylation of brain glycerophospholipids. Comparison of three acylation systems for 1-alk-1'-enylglycero-3-phosphoethanolamine, 1-acylglycero-3-phosphoethanolamine and 1-acylglycero-3-phosphocholine in rat brain microsomes.
Masuzawa Y; Sugiura T; Sprecher H; Waku K
Biochim Biophys Acta; 1989 Sep; 1005(1):1-12. PubMed ID: 2673414
[TBL] [Abstract][Full Text] [Related]
13. Acylation of endogenous phospholipids and added lysoderivatives by rat liver plasma membranes.
Colard O; Bard D; Bereziat G; Polonovski J
Biochim Biophys Acta; 1980 Apr; 618(1):88-97. PubMed ID: 7378434
[TBL] [Abstract][Full Text] [Related]
14. Formation of molecular species of mitochondrial cardiolipin 2. A mathematical model of pattern formation by phospholipid transacylation.
Schlame M
Biochim Biophys Acta; 2009 Apr; 1791(4):321-5. PubMed ID: 19416646
[TBL] [Abstract][Full Text] [Related]
15. Murine diet-induced obesity remodels cardiac and liver mitochondrial phospholipid acyl chains with differential effects on respiratory enzyme activity.
Sullivan EM; Fix A; Crouch MJ; Sparagna GC; Zeczycki TN; Brown DA; Shaikh SR
J Nutr Biochem; 2017 Jul; 45():94-103. PubMed ID: 28437736
[TBL] [Abstract][Full Text] [Related]
16. Cardiolipin remodeling: a regulatory hub for modulating cardiolipin metabolism and function.
Ye C; Shen Z; Greenberg ML
J Bioenerg Biomembr; 2016 Apr; 48(2):113-23. PubMed ID: 25432572
[TBL] [Abstract][Full Text] [Related]
17. Docosahexaenoic acid lowers cardiac mitochondrial enzyme activity by replacing linoleic acid in the phospholipidome.
Sullivan EM; Pennington ER; Sparagna GC; Torres MJ; Neufer PD; Harris M; Washington J; Anderson EJ; Zeczycki TN; Brown DA; Shaikh SR
J Biol Chem; 2018 Jan; 293(2):466-483. PubMed ID: 29162722
[TBL] [Abstract][Full Text] [Related]
18. Aberrant cardiolipin metabolism in the yeast taz1 mutant: a model for Barth syndrome.
Gu Z; Valianpour F; Chen S; Vaz FM; Hakkaart GA; Wanders RJ; Greenberg ML
Mol Microbiol; 2004 Jan; 51(1):149-58. PubMed ID: 14651618
[TBL] [Abstract][Full Text] [Related]
19. Substantial Decrease in Plasmalogen in the Heart Associated with Tafazzin Deficiency.
Kimura T; Kimura AK; Ren M; Berno B; Xu Y; Schlame M; Epand RM
Biochemistry; 2018 Apr; 57(14):2162-2175. PubMed ID: 29557170
[TBL] [Abstract][Full Text] [Related]
20. Proliferation of C6 glioma cells requires the phospholipid remodeling enzyme tafazzin independent of cardiolipin composition.
Schild L; Döring M; Jansing S; Peter D; Jagirdar G; Wolke C; Gardemann A; Lendeckel U
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Mar; 1865(3):158596. PubMed ID: 31884050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]